1-206507840-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182663.4(RASSF5):c.238G>A(p.Ala80Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,446,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000022 ( 0 hom. )
Consequence
RASSF5
NM_182663.4 missense
NM_182663.4 missense
Scores
1
2
13
Clinical Significance
Conservation
PhyloP100: 0.967
Genes affected
RASSF5 (HGNC:17609): (Ras association domain family member 5) This gene is a member of the Ras association domain family. It functions as a tumor suppressor, and is inactivated in a variety of cancers. The encoded protein localizes to centrosomes and microtubules, and associates with the GTP-activated forms of Ras, Rap1, and several other Ras-like small GTPases. The protein regulates lymphocyte adhesion and suppresses cell growth in response to activated Rap1 or Ras. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.045995712).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASSF5 | NM_182663.4 | c.238G>A | p.Ala80Thr | missense_variant | 1/6 | ENST00000579436.7 | NP_872604.1 | |
RASSF5 | NM_182664.4 | c.238G>A | p.Ala80Thr | missense_variant | 1/5 | NP_872605.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASSF5 | ENST00000579436.7 | c.238G>A | p.Ala80Thr | missense_variant | 1/6 | 1 | NM_182663.4 | ENSP00000462099 | P1 | |
RASSF5 | ENST00000581503.6 | c.238G>A | p.Ala80Thr | missense_variant | 1/4 | 1 | ENSP00000464039 | |||
RASSF5 | ENST00000580449.5 | c.238G>A | p.Ala80Thr | missense_variant | 1/5 | 1 | ENSP00000462544 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152088Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
152088
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000485 AC: 3AN: 61882Hom.: 0 AF XY: 0.0000273 AC XY: 1AN XY: 36604
GnomAD3 exomes
AF:
AC:
3
AN:
61882
Hom.:
AF XY:
AC XY:
1
AN XY:
36604
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000216 AC: 28AN: 1294064Hom.: 0 Cov.: 35 AF XY: 0.0000220 AC XY: 14AN XY: 636590
GnomAD4 exome
AF:
AC:
28
AN:
1294064
Hom.:
Cov.:
35
AF XY:
AC XY:
14
AN XY:
636590
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152088Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74308
GnomAD4 genome
AF:
AC:
6
AN:
152088
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74308
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.238G>A (p.A80T) alteration is located in exon 1 (coding exon 1) of the RASSF5 gene. This alteration results from a G to A substitution at nucleotide position 238, causing the alanine (A) at amino acid position 80 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
MutationTaster
Benign
N;N;N
PrimateAI
Pathogenic
D
Sift4G
Benign
T;T;T
Polyphen
B;B;.
Vest4
MutPred
Gain of phosphorylation at A80 (P = 0.0022);Gain of phosphorylation at A80 (P = 0.0022);Gain of phosphorylation at A80 (P = 0.0022);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at